Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients

Journal of Psychiatric Research

Volumn 35, Issue 4, 2001, Pages 239-247

  Schüle, Cornelius ^a   Baghai, Thomas ^a   Zwanzger, Peter ^a   Minov, Christo ^a   Padberg, Frank ^a   Rupprecht, Rainer ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Adrenocorticotropic hormone; Cortisol; Dexamethasone suppression test; Dexamethasone corticotropin releasing hormone test; Major depression; Sleep deprivation

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN TEST; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DOSE RESPONSE; FEMALE; HAMILTON SCALE; HORMONAL REGULATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MEASUREMENT; PRIORITY JOURNAL; SLEEP DEPRIVATION;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PITUITARY-ADRENAL SYSTEM; SLEEP DEPRIVATION; TREATMENT OUTCOME;

EID: 0034807208     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(01)00027-9     Document Type: Article

References (58)

1. Serial dexamethasone suppression tests in affective disorders
2. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment
3. Effect of interrupted sleep patterns and partial sleep deprivation on DST and mood in psychiatric house officers
4. The dexamethasone suppression test for diagnosis and prognosis in psychiatry
5. Neuroendocrinological investigations during sleep deprivation. II. Longitudinal measurement of thyrotropin, thyroid hormones, cortisol, prolactin, growth hormone, and luteinizing hormone during nights of sleep and sleep deprivation in patients with major depressive disorder
6. Quantitative rating of depressive states
7. Effects of total sleep deprivation on urinary cortisol, self-rated arousal and mood in depressed patients
8. Normalisation of the dexamethasone suppression test: A correlate of clinical improvement in primary depressives
9. Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation
10. A specific laboratory test for the diagnosis of melancholia: Standardization, validation and clinical utility
11. Persistent cortisol non-suppression after clinical recovery predicts symptomatic relapse in unipolar depression
12. The dexamethasone suppression test and ECT outcome: A six-month follow-up
13. Serial postdexamethasone cortisol levels in a patient undergoing ECT
14. Privation de sommeil et test de freination a la dexamethasone chez des volontaires sains
15. Weekly monitoring of dexamethasone suppression response in depression: Its relationship to change of body weight and psychopathology
16. Biological and behavioral effects of one night's sleep deprivation in depressed patients and normals
17. Circadian rhythm of free urinary cortisol, temperature and heart rate in endogenous depressives and under antidepressant therapy
18. Dexamethasone suppression test in antidepressant treatment of melancholia
19. Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy
20. A rating scale for depression
21. The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
22. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects
23. Repeated dexamethasone suppression test during depressive illness. Normalization of test result compared with clinical improvement
24. The corticoid receptor hypothesis of depression
25. Sustained antidepressive effect of repeated partial sleep deprivation
26. Serial partial sleep deprivation in depression - Clinical effects and dexamethasone suppression test results
27. Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment - Neurobiological and psychometric assessment of course
28. Neuroendocrine predictors of the antidepressant effect of partial sleep deprivation
29. Dexamethasone suppression test combined with total sleep deprivation in depressed patients
30. The dexamethasone suppression test and prediction of outcome in patients receiving ECT
31. The dexamethasone suppression test as a predictor of sleep deprivation antidepressant effect
32. DST in healthy volunteers and after sleep deprivation
33. Dexamethasone suppression test and sleep deprivation in endogenousdepression
34. Cortisol suppression and circadian rhythm in endogenous depression: A preliminary report
35. Sleep loss results in an elevation of cortisol levels the next evening
36. Influence of sleep disruption and calorie restriction on biological markers for depression
37. Reversal of dexamethasone nonsuppression with sleep deprivation in primary depression
38. Dexamethasone nonsuppression predicts the antidepressant effects of sleep deprivation
39. Neuroendocrine measures in psychiatric patients: Course and outcome with ECT
40. The dexamethasone suppression test as a monitor of clinical recovery
41. Depressionsverlauf nach Schlafentzug
42. The DST as a predictor of outcome in depression: A meta-analysis
43. The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder
44. The dexamethasone suppression test in patients with mood disorders
45. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression
46. Partial sleep deprivation as therapy for depression
47. Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test
48. Impact of sleep debt on metabolic and endocrine function
49. Dexamethasone suppression test before and after partial sleep deprivation in depressed schizophrenic and schizoaffective patients
50. Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: Potential clinical implications
51. Circadian profiles of melatonin in melancholic depressed patients and healthy subjects in relation to cortisol secretion and sleep
52. Manipulation of sleep and phototherapy: Non-pharmacological alternatives in the treatment of depression
53. Effect of morning and afternoon naps on mood after total sleep deprivation in patients with major depression
54. The biological basis of an antidepressant response to sleep deprivation and relapse: Review and hypothesis
55. The effects of sleep deprivation on the circadian rhythm of plasma cortisol levels in depressive patients
56. Normalization of the dexamethasone suppression test at discharge from hospital. Its prognostic value
57. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression